IP Library Granted Patent US 9,428,536
Granted Patent B2
US 9,428,536 · App. 14/159,916 · Granted Aug 30, 2016

Immunostimulatory G, U-containing oligoribonucleotides

Inventors: Grayson B. Lipford (Watertown, MA); Stefan Bauer (Marburg-Michelbach, DE); Hermann Wagner (Eching, DE)
Assignee: Zoetis Belgium SA
C07H21/02A61K31/205A61K31/712A61K31/7105A61K31/7115A61K31/7125A61K39/39A61K39/395A61K45/06C12N15/117G01N33/566A61K2039/55555C12N2310/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,428,536
App. No.
14/159,916
Granted
Aug 30, 2016
Kind
B2
Abstract

Compositions and methods relating to immunostimulatory RNA oligomers are provided. The immunostimulatory RNA molecules are believed to represent natural ligands of one or more Toll-like receptors, including Toll-like receptor 7 (TLR7) and Toll-like receptor 8 (TLR8). The compositions and methods are useful for stimulating immune activation. Methods useful for screening candidate immunostimulatory compounds are also provided.

Claims (7)

1. A synthetic G,U-rich immunostimulatory RNA oligomer which is 15-40 nucleotides long comprising multiples of 5′-GUUGB-3′, wherein B represents U, G, or C; wherein the multiples are linked through a single intervening linking nucleoside, which is selected from the group consisting of G and U.

2. The immunostimulatory RNA oligomer of claim 1 wherein B is U.

3. The immunostimulatory RNA oligomer of claim 1 or 2 , wherein the intervening linking nucleoside is U.

4. An immunostimulatory RNA oligomer of claim 1 , which comprises multiples of UUG.

5. An immunostimulatory RNA oligomer of claim 1 , which is 15-30 nucleotides long.

6. The immunostimulatory RNA oligomer of claim 1 , comprising two 5′-GUUGB-3′ motifs.

7. The immunostimulatory RNA oligomer of claim 1 , which is at least 90 percent guanine (G) and uracil (U).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2015
From: COLEY PHARMACEUTICAL GMBH
To: PFIZER ANIMAL HEALTH S.A.
Reel/Frame 035512/0363 →
CHANGE OF NAME Recorded Apr 28, 2015
From: PFIZER ANIMAL HEALTH S.A.
To: ZOETIS BELGIUM SA
Reel/Frame 035521/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2014
From: LIPFORD, GRAYSON; BAUER, STEFAN; WAGNER, HERMANN
To: COLEY PHARMACEUTICAL GMBH
Reel/Frame 034056/0380 →
Continuity (5)
Continuation 11368333 · Mar 3, 2006
Continuation 10407952 · Apr 4, 2003
Provisional Application 60421966 · Oct 29, 2002
Provisional Application 60370515 · Apr 4, 2002
Related Publication 20140135487A1 · May 15, 2014